Non-enhanced versus low-dose contrast-enhanced renal magnetic resonance angiography at 7 T: a feasibility study

Abstract

Background

Considering the currently reported association between a repetitive application and cumulative dosage of Gadolinium (Gd)-based contrast agents and Gd-deposition in brain tissue as well as the risk for the advent of nephrogenic systemic fibrosis (NSF), techniques allowing for a dose reduction become an important key aspect aside from non-enhanced magnetic resonance angiography (MRA) techniques. Thus, this study was focused on the reduction and/or complete omission of contrast agent for renal MRA at 7T.

Purpose

To evaluate the performance of time-of-flight MRA versus low-dose contrast-enhanced (CE) renal MRA at 7T.

Material and Methods

Ten healthy volunteers were examined on a 7T MR system comprising a TOF MRA and three-dimensional (3D) fast low angle shot spoiled gradient-echo sequence (FLASH) MRA after administration of one-quarter of clinical dose of gadobutrol. Qualitative image analysis was performed including overall image quality, artery delineation and presence of artifacts. Contrast ratio (CR), signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) of the renal arteries were calculated.

Results

TOF MRA and low-CE MRA achieved comparable overall ratings, with slightly superior delineation of the main renal arteries in TOF MRA (TOF = 3.10 ± 0.75, low-CE = 2.95 ± 0.75). Segmental branches outside and inside the parenchyma were delineated significantly better on TOF MRA. Quantitative analysis demonstrated the superiority of TOF MRA, yielding higher scores for CR, SNR, and CNR.

Conclusion

The initial results of our study demonstrate the feasibility and comparable diagnostic performance of TOF and low-dose CE renal MRA at 7T.

Keywords

Magnetic resonance angiography MRA 7 Tesla non-contrast-enhanced MRA low-dose contrast-enhanced MRA renal MRA

Get full access to this article

View all access options for this article.

References

Grobner

Prischl

. Gadolinium and nephrogenic systemic fibrosis. Kidney Int 2007; 72: 260–264.

Weller

Barber

Olsen

. Gadolinium and nephrogenic systemic fibrosis: An update. Pediatr Nephrol 2013; 29: 1927–1937.

Kanda

Ishii

Kawaguchi

et al.

High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014; 270: 834–841.

Vaughan

Snyder

DelaBarre

et al.

Whole-body imaging at 7T: Preliminary results. Magn Reson Med 2009; 61: 244–248.

Metzger GJ, Simonson J, Bi X, et al. Initial experience with non-contrast enhanced renal angiography at 7.0 tesla. In: Proceedings of the 18th scientific meeting, International Society for Magnetic Resonance in Medicine, Stockholm, 2010:403.

Umutlu

Kraff

Orzada

et al.

Dynamic contrast-enhanced renal MRI at 7 tesla: Preliminary results. Invest Radiol 2011; 46: 425–433.

Hagberg

Scheffler

. Effect of r1 and r2 relaxivity of gadolinium-based contrast agents on the T1-weighted MR signal at increasing magnetic field strengths. Contrast Media Mol Imaging 2013; 8: 456–465.

Shen

Goerner

Snyder

et al.

T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Invest Radiol 2015; 50: 330–338.

Habibi

Krishnam

Lohan

et al.

High-spatial-resolution lower extremity MR angiography at 3.0 T: Contrast agent dose comparison study. Radiology 2008; 248: 680–692.

10.

Tomasian

Salamon

Lohan

et al.

Supraaortic arteries: Contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography–feasibility study. Radiology 2008; 249: 980–990.

11.

Lee

Kim

Koo

et al.

Supra-aortic low-dose contrast-enhanced time-resolved magnetic resonance (MR) angiography at 3 T: Comparison with time-of-flight MR angiography and high-resolution contrast-enhanced MR angiography. Acta Radiol 2014; 56: 673–680.

12.

Beiderwellen

Kraff

Laader

et al.

Contrast enhanced renal MR angiography at 7 Tesla: How much gadolinium do we need?

Eur J Radiol 2017; 86: 76–82.

13.

Orzada S, Quick HH, Ladd ME. A flexible 8-channel transmit/receive body coil for 7 T human imaging. In: Proceedings of the 17th scientific meeting, International Society for Magnetic Resonance in Medicine, Honolulu, 2009:2999.

14.

Van de Moortele P, Ugurbil K. Very fast multi channel B1 calibration at high field in the small flip angle regime. In: Proceedings of the 17th scientific meeting, International Society for Magnetic Resonance in Medicine, Honolulu, 2009:p 367.

15.

Umutlu

Maderwald

Kinner

et al.

First-pass contrast-enhanced renal MRA at 7 tesla: Initial results. Eur Radiol 2013; 23: 1059–1066.

16.

Jiru

Klose

. Fast 3D radiofrequency field mapping using echo-planar imaging. Magn Reson Med 2006; 56: 1375–1379.

17.

Dietrich

Raya

Reeder

et al.

Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging 2008; 26: 754–762.

18.

Landis

Koch

. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.

19.

Radbruch

Weberling

Kieslich

et al.

Intraindividual analysis of signal intensity changes in the dentate nucleus after consecutive serial applications of linear and macrocyclic gadolinium-based contrast agents. Invest Radiol 2016; 51: 683–690.

20.

Kanda

Osawa

Oba

et al.

High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015; 275: 803–809.

21.

Radbruch

Weberling

Kieslich

et al.

High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol. Invest Radiol 2015; 50: 805–810.

22.

Krautmacher

Willinek

Tschampa

et al.

Brain tumors: Full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T–initial experience. Radiology 2005; 237: 1014–1019.

23.

Kalavagunta

Michaeli

Metzger

. In vitro gd-DTPA relaxometry studies in oxygenated venous human blood and aqueous solution at 3 and 7 T. Contrast Media Mol Imaging 2014; 9: 169–176.

24.

Noebauer-Huhmann

Szomolanyi

Juras

et al.

Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T1 relaxivities in human blood plasma. Invest Radiol 2010; 45: 554–558.

25.

Kuhl

Traber

Gieseke

et al.

Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. part II. technical considerations and clinical applications. Radiology 2008; 247: 16–35.

26.

Fenchel

Nael

Deshpande

et al.

Renal magnetic resonance angiography at 3.0 tesla using a 32-element phased-array coil system and parallel imaging in 2 directions. Invest Radiol 2006; 41: 697–703.

27.

Michaely

Kramer

Attenberger

et al.

Renal magnetic resonance angiography at 3.0 T: Technical feasibility and clinical perspectives. Top Magn Reson Imaging 2007; 18: 117–125.

28.

Moser

Stahlberg

Ladd

et al.

7-T MR-from research to clinical applications?

NMR Biomed 2011; 25: 695–716.